The pharmaceutical chemicals business accounts for 6% of Recordati’s total revenue. Recordati produces active ingredients for its own proprietary pharmaceuticals, active ingredients and intermediates for the generic drugs market and is engaged in the exclusive/custom manufacturing business serving major innovator big and emerging pharma organizations as well as major generic pharma organizations all over the world.

Recordati exports around 90% of its production of API’s and intermediates selling directly in over 50 countries.

For our customers in the Unites States and Canada:
Recordati Corporation
502 Centennial Avenue
P.O. Box 160
Cranford , N.J 07016 USA
Tel. ++1 908 272 7220
Fax ++1 908 272 2272